Atlas Trials

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines

Clinical trial NCT02956746 · COMPLETED

Trial details

NCT number
NCT02956746
Sponsor
Synermore Biologics Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Human Rabies
Start date
2016-08-01
Primary completion
2017-12-01
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.